Danaher Corporation

Why Danaher (DHR) Shares Are Trading Lower Today

Shares of diversified science and technology company Danaher (NYSE:DHR) fell 3.9% in the afternoon session after the company announced that Julie Sawyer Montgomery assumed the roles of president and chief executive officer and joined the board of directors.

Yahoo Finance · 01/10/2026 · lire l'article ↗

What You Need to Know Ahead of Danaher’s Earnings Release

Danaher is heading into its third-quarter earnings report in the coming weeks, and Wall Street expects modest, low-single-digit earnings growth.

Yahoo Finance · 01/10/2026 · lire l'article ↗

Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that, effective today, Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and has joined Danaher's Board of Directors, as previously announced on August 3, 2026. Since joining the Company in 2017, Ms. Sawyer Montgomery has held roles of increasing responsibility spanning commercial operations, R&D, and business leadership. In those roles, she has built a track record of advancing innovation

Yahoo Finance · 01/10/2026 · lire l'article ↗

Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team'

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced that it received two honors at the 2026 Octane High Tech Awards, winning Deal of the Year and Best Technology Company Leadership Team.

Yahoo Finance · 30/09/2026 · lire l'article ↗

Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing?

Gilead Sciences, Inc. (NASDAQ:GILD) and Danaher Corporation (NYSE:DHR) are both showing signs of stronger growth, but they are getting there in very different ways. Gilead already has momentum, which is supported by its HIV business that is expanding at a double-digit rate, with newer products contributing more and resulting in management raising its sales outlook. […]

Yahoo Finance · 28/09/2026 · lire l'article ↗

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

Leica Biosystems, a Danaher company (the "Company") and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products ("StatLab"), a leading provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity. For patients and their care teams, precision cancer diagnostics can provide critical information about the

Yahoo Finance · 28/09/2026 · lire l'article ↗